- Home
- OPEN vs INVA Comparison
OPEN vs INVA Comparison
Compare OPEN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPEN
- INVA
- Stock Information
- Founded
- OPEN 2014
- INVA 1996
- Country
- OPEN United States
- INVA United States
- Employees
- OPEN N/A
- INVA N/A
- Industry
- OPEN Real Estate
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- OPEN Finance
- INVA Health Care
- Exchange
- OPEN Nasdaq
- INVA Nasdaq
- Market Cap
- OPEN 1.1B
- INVA 1.2B
- IPO Year
- OPEN N/A
- INVA 2004
- Fundamental
- Price
- OPEN $1.44
- INVA $18.58
- Analyst Decision
- OPEN Hold
- INVA Buy
- Analyst Count
- OPEN 4
- INVA 1
- Target Price
- OPEN $2.23
- INVA N/A
- AVG Volume (30 Days)
- OPEN 40.2M
- INVA 722.9K
- Earning Date
- OPEN 02-13-2025
- INVA 02-27-2025
- Dividend Yield
- OPEN N/A
- INVA N/A
- EPS Growth
- OPEN N/A
- INVA 46.55
- EPS
- OPEN N/A
- INVA 0.99
- Revenue
- OPEN $4,939,000,000.00
- INVA $352,745,000.00
- Revenue This Year
- OPEN N/A
- INVA $16.20
- Revenue Next Year
- OPEN $20.86
- INVA N/A
- P/E Ratio
- OPEN N/A
- INVA $18.76
- Revenue Growth
- OPEN N/A
- INVA 21.46
- 52 Week Low
- OPEN $1.33
- INVA $14.33
- 52 Week High
- OPEN $3.78
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- OPEN 37.26
- INVA 63.73
- Support Level
- OPEN $1.33
- INVA $17.01
- Resistance Level
- OPEN $1.60
- INVA $17.53
- Average True Range (ATR)
- OPEN 0.11
- INVA 0.28
- MACD
- OPEN -0.01
- INVA 0.18
- Stochastic Oscillator
- OPEN 22.00
- INVA 98.12
About OPEN Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.